Correlation Between Bill and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bill and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bill and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bill Com Holdings and Carmell Therapeutics, you can compare the effects of market volatilities on Bill and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bill with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bill and Carmell Therapeutics.
Diversification Opportunities for Bill and Carmell Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Bill and Carmell is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Bill Com Holdings and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Bill is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bill Com Holdings are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Bill i.e., Bill and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Bill and Carmell Therapeutics
Given the investment horizon of 90 days Bill Com Holdings is expected to generate 0.45 times more return on investment than Carmell Therapeutics. However, Bill Com Holdings is 2.21 times less risky than Carmell Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 11,782 in Bill Com Holdings on September 2, 2024 and sell it today you would lose (2,760) from holding Bill Com Holdings or give up 23.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bill Com Holdings vs. Carmell Therapeutics
Performance |
| Timeline |
| Bill Com Holdings |
| Carmell Therapeutics |
Bill and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bill and Carmell Therapeutics
The main advantage of trading using opposite Bill and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bill position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.The idea behind Bill Com Holdings and Carmell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Carmell Therapeutics vs. Western Acquisition Ventures | Carmell Therapeutics vs. Bill Com Holdings | Carmell Therapeutics vs. Equinix | Carmell Therapeutics vs. Rumble Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |